Rasagiline Mesylate
CAS 161735-79-1 17 FDA-DMF suppliersSmall Molecule
Overview
Rasagiline Mesylate is a selective, irreversible monoamine oxidase-B inhibitor used in the treatment of Parkinson's disease. It helps to increase and sustain the levels of dopamine in the brain, thus improving motor symptoms associated with the disease.
API suppliers (13)
Suppliers of Rasagiline Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Alkem Laboratories LimitedIndia1 active DMF
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
- MICRO LABS LTDIndia1 active DMF
- F2 CHEMICALS LTD1 active DMF
- MATRIX PHARMACORP PRIVATE LTD1 active DMF
- F2 CHEMICALS LTD1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- Alkem Laboratories LimitedIndia1 active DMF
- TAI HENG INDUSTRY CO LTD1 active DMF
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
- Taro Pharmaceutical Industries Ltd.Israel
- Sun Pharmaceutical Industries LimitedIndia
- APOTEX PHARMACHEM INC
Therapeutic areas
NeurologyParkinson's Disease
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.